Watch: Biomarkers in drug development with Dr. Bernie Zeiher
By Andrew Powaleny | February 14, 2017
Biomarkers are powerful tools which are used by medical professionals in many ways, including in the diagnosis of disease, monitoring how a disease is progressing and, if a treatment is given, how...
Read More
The Science of Hope: Understanding biomarkers
By Andrew Powaleny | May 18, 2016
In the age of personalized medicine, biomarkers (short for “biological markers”) are emerging as important tools in drug development. A biomarker is a measure or physical sign that can be used to...
Read More
Lessons learned: Clinical trials
By Andrew Powaleny | May 9, 2016
A dynamic and collaborative health care ecosystem is crucial to conducting efficient and effective clinical trials, but two-thirds of trials fail to enroll enough participants. Misconceptions and...
Read More
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Coming soon: Clinical Trials Awareness Week, May 2-6
By Andrew Powaleny | April 28, 2016
Clinical trials are the most effective way to find new, innovative treatments for illnesses patients may face. But misconceptions and lack of awareness about this important research often keep...
Read More
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Week in Review: The latest from PhRMA
By Priscilla VanderVeer | March 18, 2016
ICYMI: Policy solutions for innovative treatment: Last week at our 2016 Annual Meeting, our president and CEO Steve Ubl discussed his vision for the organization and outlined policy solutions for...
Read More
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
ICYMI: American Society for Clinical Oncology statement on clinical pathways
By Kelsey Lang | January 18, 2016
Last week, the American Society for Clinical Oncology (ASCO) issued a policy statement calling for improvements in clinical pathway programs. The statement responds to the growing concern that...
Read More
New Video: Clinical trials serve as engine for local economic growth
By Priscilla VanderVeer | November 18, 2015
Without clinical trials, new medicines could not be approved and made available to the patients who need them. But beyond connecting patients to new treatments and potential cures for some of the...
Read More
Medicare Monday (100)
340B Spotlight (36)
Cost & Consequence (0)
